MARIA DEL CARMEN
OVEJERO BENITO
INVEST DOCT JUNIOR PROMETEO
Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas
Madrid, EspañaPublicacions en col·laboració amb investigadors/es de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (17)
2023
-
DNA Methylation Description of Hippocampus, Cortex, Amygdala, and Blood of Drug-Resistant Temporal Lobe Epilepsy
Molecular Neurobiology, Vol. 60, Núm. 4, pp. 2070-2085
2022
-
CNVs Associated with Different Clinical Phenotypes of Psoriasis and Anti-TNF-Induced Palmoplantar Pustulosis
Journal of Personalized Medicine, Vol. 12, Núm. 9
-
Pharmacogenetics of Donepezil and Memantine in Healthy Subjects
Journal of Personalized Medicine, Vol. 12, Núm. 5
2021
-
ABCB1 C3435T, G2677T/A and C1236T variants have no effect in eslicarbazepine pharmacokinetics
Biomedicine and Pharmacotherapy, Vol. 142
-
Epigenetics in Non-tumor Immune-Mediated Skin Diseases
Molecular Diagnosis and Therapy, Vol. 25, Núm. 2, pp. 137-161
-
Growth arrest and DNA damage-inducible proteins (GADD45) in psoriasis
Scientific Reports, Vol. 11, Núm. 1
-
Methylation in psoriasis. Does sex matter?
Journal of the European Academy of Dermatology and Venereology
2020
-
Genome-wide association analysis of psoriasis patients treated with anti-TNF drugs
Experimental Dermatology, Vol. 29, Núm. 12, pp. 1225-1232
-
Polymorphisms associated with optimization of biological therapy through drug dose reduction in moderate-to-severe psoriasis
Journal of the European Academy of Dermatology and Venereology
2019
-
Polymorphisms associated with anti-TNF drugs response in patients with psoriasis and psoriatic arthritis
Journal of the European Academy of Dermatology and Venereology
2018
-
Effect of Polymorphisms on the Pharmacokinetics, Pharmacodynamics and Safety of Sertraline in Healthy Volunteers
Basic and Clinical Pharmacology and Toxicology, Vol. 122, Núm. 5, pp. 501-511
-
Epigenetic biomarkers associated with antitumour necrosis factor drug response in moderate-to-severe psoriasis
British Journal of Dermatology
-
Histone modifications associated with biological drug response in moderate-to-severe psoriasis
Experimental Dermatology, Vol. 27, Núm. 12, pp. 1361-1371
-
How to make P-glycoprotein (ABCB1, MDR1) harbor mutations and measure its expression and activity in cell cultures?
Pharmacogenomics, Vol. 19, Núm. 16, pp. 1285-1297
-
Polymorphisms associated with adalimumab and infliximab response in moderate-to-severe plaque psoriasis
Pharmacogenomics, Vol. 19, Núm. 1, pp. 7-16
2017
-
Pharmacogenetics of trazodone in healthy volunteers: Association with pharmacokinetics, pharmacodynamics and safety
Pharmacogenomics, Vol. 18, Núm. 16, pp. 1491-1502
-
Polymorphisms associated with etanercept response in moderate-to-severe plaque psoriasis
Pharmacogenomics, Vol. 18, Núm. 7, pp. 631-638